Acomplia is an anti-obesity drug that is used to help obese people lose weight and maintain weight-loss. The active ingredient in Acomplia is rimonabant. Patients with large waist circumference (102 cm in men and 88 cm in women) will mostly benefit from taking the Rimonabant. Acomplia usage is one 20 mg tablet every day.

Acomplia is used in the treatment of obesity and related conditions by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle. It switches off the same brain circuits that make people hungry when they smoke cannabis.

The brain and fat tissue have receptors called CB1 receptors. Rimonabant stops the brain from stimulating these receptors. These receptors are responsible for stimulating the appetite. When they are blocked the desire to eat is minimized. You don’t feel like eating, so you don’t.

Acomplia is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood. Sanofi argues that Acomplia can also prevent the risk of cardiovascular disease. Acomplia has also been shown to help in smoking cessation.